Open access
Aug 2026
Canonical and isomiR products of miR-142 enhance dendritic cell reprogramming.
These findings uncover miRNA isoform diversity as a programmable regulatory layer in immune cell specification and establish RNA-driven reprogramming as a non-viral strategy for cancer immunotherapy.
Nejc Arh, I. Kurochkin, Beatriz Lourenço Vaz et al.
· Cell Reports · 0 citations